Teva Pharmaceutical Industries Limited
TEVA
Xếp hạng trong cổ phiếu
#13408
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Giá cổ phiếu
$40.38
Đồng bộ lần cuối: 2026-10-21
Vốn hóa thị trường
$470.55M
Thay đổi (1 ngày)
-2.96%
Thay đổi (1 năm)
101.80%
Quốc gia
IL
Giao dịch Teva Pharmaceutical Industries Limited (TEVA)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Teva Pharmaceutical Industries Limited (TEVA)
Giá đóng cửa cao nhất: $36.76 vào 2026-09-01
Giá đóng cửa thấp nhất: $54.24 vào 2010-06-01
Giá đóng cửa thấp nhất: $54.24 vào 2010-06-01
Lịch sử giá cổ phiếu của Teva Pharmaceutical Industries Limited từ 2010 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | 4.23% |
| 2025 | 49.61% |
| 2024 | 108.53% |
| 2023 | 2.76% |
| 2022 | 4.63% |
| 2021 | -17.41% |
| 2020 | -2.00% |
| 2019 | -49.57% |
| 2018 | 28.30% |
| 2017 | -68.90% |
| 2016 | -15.96% |
| 2015 | 6.30% |
| 2014 | 41.99% |
| 2013 | -0.79% |
| 2012 | 4.84% |
| 2011 | -27.88% |
| 2010 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $19.19 | -0.09% |
IN
|
